Paper chip enzyme-linked immunoassay test card for combined multi-tumor marker test
A tumor marker and enzyme-linked immunosorbent technology, which is applied in the field of paper chip enzyme-linked immunosorbent test cards, can solve the problems of inconvenient clinical application of tumor diagnosis, and achieve the effects of convenient on-site detection and application, high sensitivity and improved repeatability.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0049] Example 1: Detection of three tumor markers of AFP, CEA and AFU
[0050] AFP: It is an embryonic protein synthesized by the liver during the fetal period, and it is the most valuable tumor marker for detecting primary liver cancer. Under normal circumstances, it only exists in the blood of the fetus. Normal adult liver cells do not produce AFP, but when the liver cells become malignant, they can regain the ability to synthesize AFP. And there is a certain correlation between AFP content and tumor size and pathological type.
[0051] CEA: an acidic glycoprotein, which exists on the cell surface of the embryonic gastrointestinal mucosal epithelium and some malignant tissues, and is an important general tumor marker. The content of CEA in the serum of normal adults is extremely low, but it can be re-expressed when a tumor occurs, and its content has a certain relationship with the size of the tumor and whether there is metastasis. , the increase of CEA was particularly o...
Embodiment 2
[0058] Example 2: Detection of four tumor markers CEA, NSE, CYFRA21-1 and CA125
[0059] NSE: Neuron-specific enolase is an acidic protease that participates in glycolysis, and its main function is to catalyze the conversion of 2-phosphate-glycerol into enol phosphopyruvate. The glycolysis of cancer tissue is enhanced, the cell proliferation cycle is accelerated, and the release of NSE into the blood increases, resulting in an increase in the level of this enzyme in the serum. It is a tumor marker for small cell lung cancer (SCLC) and neuroblastoma. Using NSE to increase to monitor SCLC recurrence is 4-12 weeks earlier than clinically determined recurrence.
[0060] CYFRA21-1: A fragment of cytokeratin 19, mainly present in the cytoplasm of tumor cells of epithelial origin such as lung cancer and esophageal cancer. It can be released into the blood when tumor cells are lysed or necrotic, and the positive rate of CYFRA21-1 in lung cancer patients can be as high as 60% to 85%. ...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com